All In Biotech

Drug Trial Radar · NCT00441727

Study of Esomeprazole 20 mg or 40 mg vs Placebo Effectiveness on the Occurrence of Peptic Ulcers in Subjects on Low Dose Acetylsalicylic Acid (LDA)

A Randomized, Double-blind, Parallel-group, Multicentre, Phase III Study to Assess the Effect of Esomeprazole 20 or 40 mg od Versus Placebo on the Occurrence of Peptic Ulcers During 26 Weeks in Subjects on Continuous Low Dose Acetylsalicylic Acid (ASA)

Last checked: Nov 20, 2026Latest source record: Jul 16, 2012 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 2,426 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

2,426

Actual

Start

Feb 2007

Primary completion

Aug 2008

Study completion Aug 2008

Sponsor

Lead sponsor
AstraZenecaAstraZeneca (AZN)
Sponsor type
Industry
First posted
Mar 1, 2007

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Prevention
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to compare the effect of esomeprazole 20 or 40 mg once daily versus placebo on the occurrence of peptic ulcers during 26 weeks in subjects on continuous low-dose acetylsalicylic acid.

Conditions

  • Gastric Ulcer
  • Duodenal Ulcer

Interventions

  • Esomeprazole 40 mgDrug

    Esomeprazole 40 mg once daily

  • Esomeprazole 20 mgDrug

    Esomeprazole 20 mg once daily

  • PlaceboDrug

    Placebo once daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants Who Experienced the Occurence of Peptic Ulcer(s).Time frame: During 26 weeks

Locations

189 sites in 20 countries. Site status is shown where the registry gives one.

  • Research Site

    Birmingham, Alabama

  • Research Site

    Tucson, Arizona

  • Research Site

    Anaheim, California

  • Research Site

    Lancaster, California

  • Research Site

    Los Angeles, California

  • Research Site

    Orange, California

  • Research Site

    San Carlos, California

  • Research Site

    San Diego, California

  • Research Site

    Torrington, Connecticut

  • Research Site

    Boynton Beach, Florida

  • Research Site

    Hollywood, Florida

  • Research Site

    Jacksonville, Florida

  • Research Site

    Jupiter, Florida

  • Research Site

    Miami, Florida

  • Research Site

    New Smyrna Beach, Florida

  • Research Site

    Pembroke Pines, Florida

  • Research Site

    Plantation, Florida

  • Research Site

    South Miami, Florida

  • Research Site

    Tampa, Florida

  • Research Site

    Zephyrhills, Florida

  • Research Site

    Fulton, Illinois

  • Research Site

    Wichita, Kansas

  • Research Site

    Shreveport, Louisiana

  • Research Site

    Baltimore, Maryland

  • Research Site

    Hollywood, Maryland

  • Research Site

    Prince Frederick, Maryland

  • Research Site

    Brockton, Massachusetts

  • Research Site

    Jackson, Mississippi

  • Research Site

    Las Vegas, Nevada

  • Research Site

    Egg Harbor, New Jersey

  • Research Site

    Albuquerque, New Mexico

  • Research Site

    Great Neck, New York

  • Research Site

    Fayetteville, North Carolina

  • Research Site

    Greensboro, North Carolina

  • Research Site

    Jacksonville, North Carolina

  • Research Site

    Winston-Salem, North Carolina

  • Research Site

    Centerville, Ohio

  • Research Site

    Cincinnati, Ohio

  • Research Site

    Dayton, Ohio

  • Research Site

    Guthrie, Oklahoma

Showing 40 of 189 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.